Our fully integrated GxP services are driven by your assay requirements and delivered by our veteran scientists – collaboratively, accurately, and on time.
Biomarkers
Immunogenicity
Pharmacokinetics (PK)
Cell-Based Assays
Our team is comprised of recognized experts in effectively navigating complex and evolving opportunities for biotherapeutics innovation.
Biosimilars
Gene Therapy
Antibody Drug Conjugates (ADCs)
Immuno-oncology
Explore the BioAgilytix way of thinking. Visit our Resource Center to learn more about our scientists’ expertise through case studies, blogs, industry articles and other scientific resources.
Quick links to our latest content offerings:
LinkedIn Company Updates
1 Day Agoview on linkedin
We are excited to announce that our USA headquarters will be expanding again, this time by an additional 21,000+ square feet. The expansion will further grow capacity for all of our bioanalytical services and support our growing team: https://lnkd.in/e6isdmd
1 Day Agoview on linkedin
BioAgilytix Europe is seeking a Data Controller to support verification of study data in close collaboration with our laboratory and quality assurance staff. If you are interested in joining our team in Hamburg, apply today: https://lnkd.in/egCYZ_Z
2 Days Agoview on linkedin
Stanford University School of Medicine researchers have demonstrated that gene therapy can be effective without causing an autoimmune reaction to the normal protein, which the patient's immune system is encountering for the first time: https://lnkd.in/e9F7-QD via ScienceDaily
September 12, 2018New Research on the Diagnostic Journey of Patients with Ankylosing Spondylitis
September 5, 2018Platform Spotlight: Biacore™ to Detect and Characterize ADAs in Immunogenicity Studies
September 18, 2018BioAgilytix Announces Extensive Facilities Expansion Plan at Its USA Headquarters
August 15, 2018BioAgilytix Named to Inc. Magazine’s Inc. 5000 List of Fastest-Growing Private U.S. Companies for Fifth Time
May 9, 2018Evaluating the Immunogenicity of Antibody–drug Conjugates
April 16, 2018Strategies for Development and Validation of Neutralizing Antibody Assays Supporting Biosimilars
Services
Platforms
